SCHEMBL13060641

SCHEMBL13060641

CCc1cccc(-c2cccc(C(=O)N[C@H](CN(C)C)C3CCCCC3)c2)c1OC

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPK1 P28482 1/20 0.41
KMT2A Q03164 1/20 0.41
BRD4 O60885 1/20 0.39
CREBBP Q92793 1/20 0.39
CTSL P07711 2/20 0.38
CTSS P25774 2/20 0.38
ROCK2 O75116 2/20 0.38
ROCK1 Q13464 2/20 0.38
CTSK P43235 1/20 0.38
CNR1 P21554 2/20 0.37
CNR2 P34972 2/20 0.37
ERN1 O75460 1/20 0.37
HPGD P15428 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CD274 Q9NZQ7 1/20 0.37
FAAH O00519 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13005623 0.92 BRD4 (0.39) MEN1ALDH1A1MAPK1KMT2ABRD4
SCHEMBL13060805 0.86 CTSS (0.44) MEN1KMT2ACTSLCTSSROCK2
SCHEMBL13060644 0.86 CTSS (0.44) MEN1KMT2ACTSLCTSSROCK2
SCHEMBL172990 0.84 CTSL (0.33) MEN1ALDH1A1MAPK1KMT2ABRD4
SCHEMBL13061081 0.82 SMYD3 (0.44) MEN1ALDH1A1KMT2AROCK2ROCK1
SCHEMBL13060892 0.81 CTSL (0.41) CTSLCTSSROCK2ROCK1CTSK
SCHEMBL13060890 0.81 CTSL (0.41) CTSLCTSSROCK2ROCK1CTSK
SCHEMBL13060800 0.81 TAS1R3 (0.41) ROCK2ROCK1
SCHEMBL13061114 0.81 TAS1R3 (0.41) ROCK2ROCK1
SCHEMBL13061023 0.79 ROCK2 (0.51) ROCK2ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed